Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized clinical trials

Detalles Bibliográficos
Autores principales: Yu, Yunfang, Chen, Yongjian, Li, Anlin, Ou, Qiyun, Li, Qingjian, Gu, Yang, Lin, Dagui, Zhang, Wenda, Wang, Jingshu, Tang, Xudong, Li, Zhihua, Hu, Hai, Yao, Herui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403831/
https://www.ncbi.nlm.nih.gov/pubmed/32508050
http://dx.doi.org/10.1002/ctm2.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403831/
https://www.ncbi.nlm.nih.gov/pubmed/32508050
http://dx.doi.org/10.1002/ctm2.53

Ejemplares similares